| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.061 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.023 | 0.9 |